Apelin-13 (human, bovine, mouse, rat) CAS NO.217082-58-1

Apelin-13 (human, bovine, mouse, rat) CAS NO.217082-58-1

Apelin-13 (human, bovine, mouse, rat) CAS NO.217082-58-1

Apelin-13 (human, bovine, mouse, rat) CAS NO.217082-58-1

Apelin-13 (human, bovine, mouse, rat) CAS NO.217082-58-1

Apelin-13 (human, bovine, mouse, rat) (CAS NO. 217082-58-1) is a synthetic tridecapeptide representing the predominant, highly active C-terminal fragment of the endogenous Apelin peptide. This sequence (e.g., human: Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe) is considered one of the most potent endogenous ligands for the G protein-coupled Apelin receptor (APJ/APLNR). It is a key regulator of cardiovascular function, fluid balance, and metabolism, and serves as a critical research tool in cardiovascular, metabolic, and central nervous system studies.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 Apelin‑13 (human, bovine, mouse, rat)
CAS NO.
217082‑58‑1
Appearance
White to off-white lyophilized powder
Molecular Formula
C₆₉H₁₀₈N₂₂O₁₅S
Molecular Weight
 1654.80g/mol
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥5 mg/mL); soluble in 5% acetic acid or DMSO

Endotoxin< 1.0 EU/mg
Biological Activity
Potent and endogenous agonist for APJ receptor; improves cardiac contractility, induces vasodilation, regulates fluid homeostasis, angiogenesis and energy metabolism.
Storage Conditions
Store at ‑20°C; long‑term at ‑80°C. Protect from light and moisture. Avoid repeated freeze‑thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Apelin-13 exerts its effects by binding to and activating the Apelin receptor (APJ), triggering tissue-specific G protein signaling:
  1. Cardiovascular System (Predominantly Gi/o Coupling):
    • Vasodilation: Activates endothelial Gi/o proteins, leading to eNOS phosphorylation, nitric oxide (NO) production, and vasodilation. It also antagonizes Angiotensin II signaling, opposing the Renin-Angiotensin System (RAS).
    • Positive Inotropy: In the heart, it increases contractility through mechanisms that may involve both Gi and Gq pathways, enhancing cardiac output without increasing heart rate.
  2. Central Nervous System: In the hypothalamus, it modulates fluid intake (reduces thirst), appetite, and neuroendocrine axes via APJ receptors.
  3. Metabolism: In adipose tissue, it enhances glucose uptake and insulin sensitivity.
  4. Angiogenesis: Promotes new blood vessel formation.

  

2.PRODUCT INDICATIONS

This peptide is widely used in diverse areas of physiological and pharmacological research. Key applications include:
  • Cardiovascular Research: Investigating its role as a vasodilator, inotropic agent, and cardioprotective factor in models of hypertension, heart failure, myocardial infarction, and pulmonary arterial hypertension.
  • Metabolism & Diabetes Research: Studying its effects on insulin sensitivity, glucose disposal, and adipose tissue function in models of obesity and type 2 diabetes.
  • Neuroscience: Exploring central roles in body fluid homeostasis (dipsogenesis), feeding behavior, neuroprotection, and mood disorders.
  • Angiogenesis & Cancer: Researching its pro-angiogenic effects in both physiological repair and pathological contexts like tumor growth.
  • Drug Discovery: Serving as the reference standard agonist for screening novel APJ receptor modulators (agonists/antagonists).

  

3.CLINICAL EFFICACY OF PRODUCT

Apelin-13 itself is in early-phase clinical investigation, demonstrating significant translational potential from robust preclinical data.
  • Cardiovascular Therapeutics: Preclinical studies consistently show Apelin-13 can lower blood pressure, improve cardiac function in heart failure, and protect the heart from ischemic injury. Early human clinical trials (Phase I/IIa) in patients with heart failure have demonstrated that intravenous Apelin-13 infusion produces potent peripheral and coronary vasodilation, increases cardiac output, and reduces preload and afterload with a favorable safety profile. It represents a promising novel therapy for acute heart failure.
  • Metabolic Disease Target: Its insulin-sensitizing effects in animals highlight its potential for treating metabolic syndrome and type 2 diabetes.
  • Validated Target: Research with Apelin-13 has been instrumental in validating the APJ receptor as a major therapeutic target, leading to significant investment in developing stable APJ agonists for cardiovascular and metabolic diseases. 

  

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.